- Home
- APLT vs SYT Comparison
APLT vs SYT Comparison
Compare APLT & SYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- SYT
- Stock Information
- Founded
- APLT 2016
- SYT 2010
- Country
- APLT United States
- SYT Japan
- Employees
- APLT N/A
- SYT N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- SYT Real Estate
- Sector
- APLT Health Care
- SYT Finance
- Exchange
- APLT Nasdaq
- SYT Nasdaq
- Market Cap
- APLT 37.5M
- SYT 41.2M
- IPO Year
- APLT 2019
- SYT 2023
- Fundamental
- Price
- APLT $0.40
- SYT $1.84
- Analyst Decision
- APLT Buy
- SYT
- Analyst Count
- APLT 7
- SYT 0
- Target Price
- APLT $6.10
- SYT N/A
- AVG Volume (30 Days)
- APLT 1.9M
- SYT 6.6K
- Earning Date
- APLT 05-20-2025
- SYT 05-20-2025
- Dividend Yield
- APLT N/A
- SYT 0.33%
- EPS Growth
- APLT N/A
- SYT N/A
- EPS
- APLT N/A
- SYT 0.08
- Revenue
- APLT $455,000.00
- SYT $149,124,408.00
- Revenue This Year
- APLT $1,768.13
- SYT N/A
- Revenue Next Year
- APLT $361.28
- SYT N/A
- P/E Ratio
- APLT N/A
- SYT $25.78
- Revenue Growth
- APLT N/A
- SYT 3.11
- 52 Week Low
- APLT $0.30
- SYT $1.18
- 52 Week High
- APLT $10.62
- SYT $3.90
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- SYT 32.97
- Support Level
- APLT $0.39
- SYT $1.60
- Resistance Level
- APLT $0.44
- SYT $2.50
- Average True Range (ATR)
- APLT 0.04
- SYT 0.19
- MACD
- APLT 0.01
- SYT -0.05
- Stochastic Oscillator
- APLT 45.49
- SYT 26.70
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SYT SYLA Technologies Co. Ltd.
SYLA Technologies Co Ltd is a property technology company. It provides asset management platform systems that facilitate real estate crowd-funding as well as the purchase and sale of real estate.